Results 21 to 30 of about 16,340 (253)

Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports

Einstein (São Paulo), 2020
Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho, Francisco Leonardo Galastri, Breno Boueri Affonso, Priscila Mina Falsarella, Leonardo Guedes Moreira Valle, Ben-Hur Ferraz-Neto, Marcelo Bruno de Rezende, Joaquim Maurício da Motta-Leal-Filho, Rodrigo Gobbo Garcia, Felipe Nasser   +9 more
doaj   +2 more sources

EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres

EJNMMI Physics, 2021
The aim of this standard operational procedure is to standardize the methodology employed for the evaluation of pre- and post-treatment absorbed dose calculations in 90 Y microsphere liver radioembolization.
C. Chiesa, Katarina Sjogreen-Gleisner, S. Walrand, L. Strigari, G. Flux, J. Gear, C. Stokke, P. M. Gabiña, P. Bernhardt, M. Konijnenberg   +9 more
semanticscholar   +1 more source

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings

Asian Journal of Surgery, 2016
Background: Radioembolization with yttrium microspheres is an established therapeutic modality for primary and secondary hepatic malignancies, with studies demonstrating improved overall survival.
Sagun Parakh, Sivakumar Gananadha, Robert Allen, Desmond Yip   +3 more
doaj   +1 more source

Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. [PDF]

, 2016
Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage, beyond potentially curative options.
Alanis, Lourdes, Cho, Sung-Ki, Lee, Edward Wolfgang, Saab, Sammy   +3 more
core   +1 more source

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol

BMC Cancer, 2023
Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remnant hypertrophy—has ...
Daan Andel, Marnix G. E. H. Lam, Joep de Bruijne, Maarten L. J. Smits, Arthur J. A. T. Braat, Adriaan Moelker, Erik Vegt, Simeon J. S. Ruiter, Walter Noordzij, Gianluca Grazi, Giulio E. Vallati, Roel J. Bennink, Otto M. van Delden, Onno W. Kranenburg, Jan N. M. Ijzermans, Maarten W. Nijkamp, Joris I. Erdmann, Rosa Sciuto, Jeroen Hagendoorn, Inne H. M. Borel Rinkes   +19 more
doaj   +1 more source

Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE) : study protocol for a randomized controlled trial [PDF]

, 2012
Background: Hepatocellular carcinoma is a primary malignant tumor of the liver that accounts for an important health problem worldwide. Only 10 to 15% of hepatocellular carcinoma patients are suitable candidates for treatment with curative intent, such ...
Al Younis, Imad, Coenraad, Minneke J, Defreyne, Luc, Lam, Marnix GEH, Lambert, Bieke, Seinstra, Beatrijs A, van den Bosch, Maurice AAJ, van Erkel, Arian R, van Erpecum, Karel J, van Hoek, Bart, Van Vlierberghe, Hans, Verkooijen, Helena M   +11 more
core   +1 more source

Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.

PLoS ONE, 2016
Background/aimsLimited treatment options are available for patients with hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Transarterial radioembolization using Yttrium-90 microspheres is a new treatment modality for HCC with PVT.
Young Youn Cho, Minjong Lee, Hyo-Cheol Kim, Jin Wook Chung, Yun Hwan Kim, Geum-Youn Gwak, Si Hyun Bae, Do Young Kim, Jeong Heo, Yoon Jun Kim   +9 more
doaj   +1 more source

Quantitative pretreatment VOI analysis of liver metastases 99mTc-MAA SPECT/CT and FDG PET/CT in relation with treatment response to SIRT [PDF]

, 2013
Using quantitive VOI analysis, the percentage Tc-99m-MAA uptake and SUVmax and mean values of liver metastases obtained prior to SIRT were related to treatment response using both a lesion-based and clinical dichotomous approach. Based on the VOI % of Tc-
Beels, L, Brugman, E, D'Asseler, Yves, De Spiegeleer, Bart, Maes, A, Mees, Gilles, Stellamans, K, Van De Wiele, Christophe   +7 more
core   +2 more sources

Transarterial Radioembolization for Management of Hepatocellular Carcinoma

The Oncologist, 2023
Transarterial radioembolization (TARE) with Yttrium-90 (Y90) is a growing area of study due to its benefits in early-, intermediate-, and late-stage hepatocellular carcinoma.
W. Badar, Qian Yu, Mikin V Patel, Osman Ahmed   +3 more
semanticscholar   +1 more source

Radiation segmentectomy for hepatic malignancies: Indications, devices, dosimetry, procedure, clinical outcomes, and toxicity of yttrium-90 microspheres

Journal of Interventional Medicine, 2019
Radiation segmentectomy (RS) is a new approach to 90Y radioembolization that has been designed to increase the safety and efficacy of radioembolization in patients with unresectable hepatic malignancies.
Zhongzhi Jia, Caoye Wang, Ricardo Paz-Fumagalli, Weiping Wang   +3 more
doaj   +1 more source